Literature DB >> 28385900

Oral isotretinoin: ensuring safe use while not limiting access to those who need it.

Jerry K L Tan1, Neil Shear2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28385900      PMCID: PMC5378515          DOI: 10.1503/cmaj.732920

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Management of acne: Canadian clinical practice guideline.

Authors:  Yuka Asai; Akerke Baibergenova; Maha Dutil; Shannon Humphrey; Peter Hull; Charles Lynde; Yves Poulin; Neil H Shear; Jerry Tan; John Toole; Catherine Zip
Journal:  CMAJ       Date:  2015-11-16       Impact factor: 8.262

2.  High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.

Authors:  Rachel C Blasiak; Christopher R Stamey; Craig N Burkhart; Aida Lugo-Somolinos; Dean S Morrell
Journal:  JAMA Dermatol       Date:  2013-12       Impact factor: 10.282

3.  The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system.

Authors:  Janet Shin; T Craig Cheetham; Linda Wong; Fang Niu; Elizabeth Kass; Monica A Yoshinaga; Mike Sorel; Jeffrey S McCombs; Stephen Sidney
Journal:  J Am Acad Dermatol       Date:  2011-05-11       Impact factor: 11.527

Review 4.  Guidelines of care for the management of acne vulgaris.

Authors:  Andrea L Zaenglein; Arun L Pathy; Bethanee J Schlosser; Ali Alikhan; Hilary E Baldwin; Diane S Berson; Whitney P Bowe; Emmy M Graber; Julie C Harper; Sewon Kang; Jonette E Keri; James J Leyden; Rachel V Reynolds; Nanette B Silverberg; Linda F Stein Gold; Megha M Tollefson; Jonathan S Weiss; Nancy C Dolan; Andrew A Sagan; Mackenzie Stern; Kevin M Boyer; Reva Bhushan
Journal:  J Am Acad Dermatol       Date:  2016-02-17       Impact factor: 11.527

5.  Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.

Authors:  Allen Brinker; Cynthia Kornegay; Parivash Nourjah
Journal:  Arch Dermatol       Date:  2005-05

6.  Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study.

Authors:  Anders Sundström; Lars Alfredsson; Gunilla Sjölin-Forsberg; Barbro Gerdén; Ulf Bergman; Jussi Jokinen
Journal:  BMJ       Date:  2010-11-11

7.  Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne.

Authors:  Jerry K L Tan; Yudi Li; Karen Fung; Aditya K Gupta; D Richard Thomas; Sheetal Sapra; Charles Lynde; Yves Poulin; Wayne Gulliver; Rolf J Sebaldt
Journal:  J Cutan Med Surg       Date:  2008 Sep-Oct       Impact factor: 2.092

8.  Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.

Authors:  David Henry; Colin Dormuth; Brandace Winquist; Greg Carney; Shawn Bugden; Gary Teare; Linda E Lévesque; Anick Bérard; J Michael Paterson; Robert W Platt
Journal:  CMAJ       Date:  2016-04-25       Impact factor: 8.262

Review 9.  What is the best approach to reducing birth defects associated with isotretinoin?

Authors:  Lorien Abroms; Edward Maibach; Katherine Lyon-Daniel; Steven R Feldman
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.